The NJR provides a service to help NHS organisations achieve transparency in implant pricing
Price Benchmarking started as a Department of Health (DH) initiative under the Quality, Innovation, Productivity, and Prevention (QIPP) programme. Although funding for the pilot was provided by DH, Price Benchmarking now forms a core part of the NJR. Trusts provide pricing data to the NJR from the pricing catalogues they receive from implant suppliers and the implant and price is matched to procedures held in the NJR where the same implant has been used. Linking the pricing information to NJR data has the following benefits:
- Price is linked to usage
- Implant combinations used in procedures are linked
- Implants are linked to surgeons
- It supports the clinical evidence of implants
- It supports analysis by patient demographics
From the resulting analysis it is possible to determine the variation in price paid for implants throughout the NHS.
The INFORM service is provided to trusts and health boards as part of their subscription to the NJR. An INFORM report includes information on implant usage and spend by manufacturer, implant pricing comparison against national benchmarks, estimated savings, implant costs by surgeon, manufacturer and joint by surgeon, and brand costs and use (including potential savings). As at 31 March 2016, 73 trusts and health boards were providing pricing data to the NJR with, however, only 61 of those providing useable data.
The advanced reporting service, EMBED, is a subscription service that enables procurement and healthcare management teams to drill down further into their pricing data. It also provides surgeons with individual reports which are made available to them via NJR Clinician Feedback. Reports include:
- A surgeon’s procedures including joint, type, patient status (age and ASA grade) and implant costs.
- A surgeon’s procedure details by type and joint, manufacturer, catalogue numbers, brand, and cost by component and the cost of the whole procedure.
- Enhanced analytics including implant cost by patient type, surgeon-level mean implant cost, age profile, uses of ceramics, cost and clinical evidence.
All reports can be categorised by joint type, stage (primary or revision), procedure type, age group, gender, ASA grade, and cost profile.
As at 31 March 2016, 16 trusts and health boards were subscribing to the EMBED service.
Following feedback from hospitals, the NJR has also started to look at views of pricing data associated with outcomes data. This work is in its early stages.
Further information about Price Benchmarking and the INFORM and EMBED services is available from the ‘Implant procurement’ tab on the NJR website.